Midazolam Infusion for Status Epilepticus
For refractory status epilepticus not controlled by standard therapies, midazolam should be administered as an IV loading dose of 0.15-0.20 mg/kg, followed by a continuous infusion starting at 1 mg/kg per minute and increasing by 1 mg/kg per minute increments every 15 minutes as needed, up to a maximum of 5 mg/kg per minute until seizures stop. 1
Dosing Protocol
Initial Loading Dose
- IV loading dose: 0.15-0.20 mg/kg 1
- This should be administered immediately upon determination that status epilepticus is refractory to standard first-line therapies 2
Continuous Infusion
- Start at 1 mg/kg per minute 1
- Increase by increments of 1 mg/kg per minute every 15 minutes 1
- Maximum dose: 5 mg/kg per minute 1
- Continue titration until seizures stop 1
Alternative Routes When IV Access is Challenging
- IM administration: 0.2 mg/kg (maximum: 6 mg per dose) 1
- May repeat IM dose every 10-15 minutes as needed 1
- Note that IM administration has been shown to be more effective than intranasal administration in real-world settings 3
Monitoring and Safety Considerations
Respiratory Monitoring
- Increased incidence of apnea when combined with other sedative agents 1
- Be prepared to provide respiratory support regardless of administration route 1
- Continuous oxygen saturation monitoring is essential 1
Reversal Agent Considerations
- Flumazenil may be administered to reverse life-threatening respiratory depression 1
- Important caveat: Flumazenil will also reverse the anticonvulsant effects and may precipitate recurrence of seizures 1
Clinical Efficacy
- Midazolam has proven to be effective, well-tolerated, and fast-acting for refractory status epilepticus 2
- Pharmacodynamic effects can be seen within 1-5 minutes of administration 2
- Anticonvulsive effects typically appear within 5-15 minutes after administration 2
- Clinical studies have documented cessation of seizure activity within minutes of the loading dose 4
Treatment Algorithm for Status Epilepticus
- First-line therapy: Standard benzodiazepines (lorazepam, diazepam) 1
- Second-line therapy: Phenytoin/fosphenytoin, valproate, or levetiracetam 1
- For refractory status epilepticus (seizures continuing after steps 1 and 2):
Common Pitfalls and Caveats
- Underdosing is a common pitfall - higher doses are associated with lower risk of rescue therapy 3
- Hemodynamic instability may occur with prolonged infusions - monitor for hypotension 4
- Withdrawal symptoms may occur with abrupt discontinuation - consider progressive reduction of doses when discontinuing 5
- Concurrent treatment of underlying causes of status epilepticus (hypoglycemia, hyponatremia, hypoxia, drug toxicity, CNS infection) is essential 1